ARNm THÉRAPEUTIQUES
Bibliographie
R. Chèvre, O. Le Bihan, F. Beilvert et al., « Amphiphilic block copolymers enhance the cellular uptake of DNA molecules through a facilitated plasma membrane transport », in NucleicAcidsResearch, vol. 39, n° 4, pp. 1610-1622, 2011 (https://doi.org/10.1093/nar/gkq922)
T. Colombani, P. Peuziat, L. Dallet et al., « Self-assembling complexes binary mixtures of lipids with different linkers and nucleic acids promote universal mRNA, DNA and siRNA delivery », in Journal of Control Release, vol. 249, pp. 131-142, 2017 (https://doi.org/10.1016/j.jconrel.2017.01.041)
A. Gupta, J. L. Andresen, R. S. Manan & R. Langer, « Nucleic acid delivery for therapeutic applications », in Advanced Drug Delivery Reviews, vol. 178, n° 113834, 2021
D. Habrant, P. Peuziat, T. Colombani et al., « Design of ionizable lipids to overcome the limiting step of endosomal escape: Application in the intracellular delivery of mRNA, DNA and siRNA », in Journal of Medicinal Chemistry, vol. 59, n° 7, pp. 3046-3062, 2016
X. Hou, T. Zaks, R. Langer & Y. Dong, « Lipid nanoparticles for mRNA delivery », in Nature Reviews Materials, vol. 6, pp. 1078-1094, 2021 (https://www.nature.com/articles/s41578-021-00358-0)
K. E. Lindsay, S. M. Bhosle, C. Zurla et al., « Visualization of early events in mRNA vaccine delivery in non-human primates via PET/CT and near-infrared imaging », in Nature Biomedical Engineering, vol. 3, pp. 371-380, 2019 (https://www.nature.com/articles/s41551-019-0378-3)
B. Pitard, « Capped and uncapped RNA molecules and block copolymers for intracellular delivery of RNA », n° publ. WO/2015/151048, 2015 (https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2015151048)
B. Pitard & D. Habrant, « Supramolecular gene transfection agents », in ComprehensiveSupramolecular Chemistry II, vol. 5, pp. 365-389, 2017
E. Rohner, R. Yang, K. S. Foo et al., « Unlocking the promise of mRNA therapeutics », in Nature Biotechnology, vol. 40, pp. 1586-1600, 2022 (https://www.nature.com/articles/s41587-022-01491-z).
La suite de cet article est accessible aux abonnés
- Des contenus variés, complets et fiables
- Accessible sur tous les écrans
- Pas de publicité
Déjà abonné ? Se connecter
Écrit par
- Bruno PITARD : directeur de recherche CNRS, unité immunology and new concepts in immunotherapy, Nantes université
Classification
Médias